You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Patent: 10,184,001


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,184,001
Title:Effector-deficient anti-CD32a antibodies
Abstract: Effector-deficient anti-CD32a monoclonal antibodies are encompassed, as are method and uses for treating CD32a-mediated diseases and disorders, including, thrombocytopenia, allergy, hemostatic disorders, immune, inflammatory, and autoimmune disorders.
Inventor(s): Francis; John (Longwood, FL), Amirkhosravi; Ali (Longwood, FL), Meyer; Todd (Longwood, FL), Robles-Carrillo; Liza (Rockledge, FL)
Assignee: Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL)
Application Number:15/171,734
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,184,001

Introduction

When analyzing a patent, particularly one like United States Patent 10,184,001, it is crucial to delve into the claims, the patent landscape, and the broader context of U.S. patent law. This analysis will help in understanding the patent's validity, its position within the industry, and its potential impact.

Understanding the Patent Claims

To begin with, it is essential to understand the claims of the patent. The claims are the heart of any patent, as they define the scope of the invention and what is protected.

Claim Structure and Hierarchy

The claims of a patent are typically structured in a hierarchical manner, with independent claims and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims narrow down the invention by adding specific limitations[2].

For a comprehensive analysis, one must parse the claims to separate each claim element and arrange them in their hierarchical order. This can be facilitated by tools like the Patent Claims Analysis System, which automates the process of importing, parsing, and compressing claims for easier review[2].

Patentability Criteria Under U.S. Law

U.S. patent law, specifically Sections 101, 102, and 103, provides the framework for determining the validity of patent claims.

Section 101: Patentable Subject Matter

Section 101 sets forth what constitutes patentable subject matter. The Supreme Court's decision in Alice Corp. v. CLS Bank International established a two-step test to determine if a claim is eligible for patenting. First, determine if the claim is directed to a process, machine, manufacture, or composition of matter. If so, proceed to the second step, which involves determining if the claim is directed towards a law of nature, a natural phenomenon, or an abstract idea[3].

Section 102: Novelty

Section 102 deals with the novelty requirement. A patent claim must be novel, meaning it must not be anticipated by prior art. Conducting extensive prior art searches is crucial to ensure that the claims are novel and to refine them to avoid existing patents[3].

Section 103: Non-Obviousness

Section 103 addresses non-obviousness. The claim must be non-obvious over the prior art, meaning it must represent a significant improvement or innovation that would not be obvious to a person of ordinary skill in the relevant field. Strategic claim drafting and effective argumentation are key in demonstrating non-obviousness[3].

Patent Landscape Analysis

A patent landscape analysis provides a snapshot of the intellectual property outlook for a given technology, industry, or company.

Global Dossier and International Search

To understand the global patent landscape, tools like the Global Dossier can be used. This service provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family and related applications filed at different offices[1].

Patent Classification Systems

Using patent classification systems, such as those provided by the USPTO or international offices like the European Patent Office (EPO), can help in organizing and searching for patents within specific technology groupings. This ensures that the search results are highly relevant and saves time[1][5].

Advanced Patent Searching Techniques

Advanced patent searching goes beyond the basics and involves several key strategies:

Claims Variation

During the prosecution process, claims may be amended or narrowed in response to objections from the examiner. This means that related patents within the same patent family may have different claims after prosecution. Identifying these variations is crucial for a comprehensive analysis[4].

Prior Art Searches

Conducting extensive prior art searches is essential to identify potential obstacles and refine claims to ensure novelty and non-obviousness. Tools like the Common Citation Document (CCD) can consolidate prior art cited by multiple offices, making it easier to visualize and analyze the data[1].

Patent Assignment and Ownership

Understanding the ownership and assignment history of a patent can provide insights into its commercial and strategic value. The Patent Assignment Search website can be used to search for patent assignments and changes in ownership[1].

Practical Insights and Strategic Considerations

Detailed Prior Art Analysis

A thorough prior art analysis is vital to ensure that the patent claims are novel and non-obvious. This involves analyzing existing patents and publications in the relevant field to identify potential obstacles and refine the claims accordingly[3].

Strategic Claim Drafting

Crafting claims that are broad enough to offer substantial protection yet specific enough to circumvent prior art is a delicate balance. The focus should be on highlighting the unique aspects of the invention that render it eligible, novel, and non-obvious[3].

Effective Argumentation

Building compelling arguments around eligibility, novelty, and non-obviousness is crucial. This involves explaining the technological advancements brought about by the invention and distinguishing it clearly from the existing state of the art[3].

Tools and Resources for Patent Analysis

Patent Public Search

The USPTO's Patent Public Search tool provides enhanced access to prior art with modern interfaces and flexible capabilities. This tool can significantly improve the overall patent searching process[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for conducting a comprehensive patent search[1].

PatentsView

PatentsView is a visualization, data dissemination, and analysis platform that focuses on intellectual property data. It can help researchers explore, visualize, and analyze complex patent data[5].

Case Studies and Real-World Applications

Alice Corp. v. CLS Bank International

The Alice Corp. v. CLS Bank International case highlights the importance of aligning innovations with the requirements of Section 101. Innovators must focus on the tangible and applicable aspects of the invention to avoid issues related to abstract ideas[3].

Key Takeaways

  • Comprehensive Claim Analysis: Understanding the hierarchical structure and content of the claims is crucial for determining the scope of the invention.
  • Patentability Criteria: Ensuring that the patent meets the criteria under Sections 101, 102, and 103 of U.S. patent law is essential for its validity.
  • Global Patent Landscape: Analyzing the global patent landscape using tools like the Global Dossier and international patent databases helps in understanding the broader intellectual property context.
  • Advanced Searching Techniques: Identifying claims variations, conducting thorough prior art searches, and using advanced tools like the CCD are vital for a comprehensive analysis.
  • Strategic Considerations: Strategic claim drafting, detailed prior art analysis, and effective argumentation are key to navigating the nuances of patent law.

FAQs

Q: What are the key sections of U.S. patent law that affect patent claims? A: Sections 101, 102, and 103 are pivotal, dealing with patentable subject matter, novelty, and non-obviousness, respectively[3].

Q: How can I conduct a comprehensive prior art search? A: Use tools like the Common Citation Document (CCD) and patent classification systems to ensure thorough and relevant results[1][3].

Q: What is the importance of the Global Dossier in patent searching? A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping users understand the global patent family and related applications[1].

Q: How do claims variations affect patent analysis? A: Claims variations during the prosecution process can result in different claims across related patents within the same patent family, making it crucial to identify these variations for a comprehensive analysis[4].

Q: What tools are available for visualizing and analyzing patent data? A: Tools like PatentsView and the Patent Public Search tool offer advanced capabilities for visualizing, disseminating, and analyzing complex patent data[1][5].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - US20110138338A1: https://patents.google.com/patent/US20110138338A1/en
  3. TT Consultants - Exploring Sections 101, 102, & 103 of U.S. Patent Law: https://ttconsultants.com/navigating-the-nuances-a-comprehensive-exploration-of-sections-101-102-and-103-of-u-s-patent-law/
  4. CAS.org - Advanced patent searching techniques: https://www.cas.org/resources/cas-insights/patent-searching-going-beyond-basics-increase
  5. Brown University Library Guides - Patents: https://libguides.brown.edu/patent

More… ↓

⤷  Subscribe

Details for Patent 10,184,001

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 August 24, 1998 ⤷  Subscribe 2034-11-26
Immunex Corporation ENBREL etanercept For Injection 103795 November 02, 1998 ⤷  Subscribe 2034-11-26
Immunex Corporation ENBREL etanercept For Injection 103795 May 27, 1999 ⤷  Subscribe 2034-11-26
Immunex Corporation ENBREL etanercept Injection 103795 September 27, 2004 ⤷  Subscribe 2034-11-26
Immunex Corporation ENBREL etanercept Injection 103795 February 01, 2007 ⤷  Subscribe 2034-11-26
Immunex Corporation ENBREL MINI etanercept Injection 103795 September 14, 2017 ⤷  Subscribe 2034-11-26
Immunex Corporation ENBREL etanercept Injection 103795 ⤷  Subscribe 2034-11-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.